IRFI-042

N/A

Report date: 2024/12/05 16:47:20

Base Information

Drug NameIRFI-042

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionLipid peroxidation inhibitorsTumor necrosis factor α inhibitors

TargetsTumor necrosis factor α

Therapy Area/IndicationsReperfusion InjuryAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiomedica Foscama

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiomedica Foscama

Active IndicationsN/A

Inactive IndicationsReperfusion InjuryAtherosclerosis

ATC CodeN/A